Cargando…

Severe clinical relapse in an immunocompromised host with persistent SARS-CoV-2 infection

Detalles Bibliográficos
Autores principales:	Reuken, Philipp A., Stallmach, Andreas, Pletz, Mathias W., Brandt, Christian, Andreas, Nico, Hahnfeld, Sabine, Löffler, Bettina, Baumgart, Sabine, Kamradt, Thomas, Bauer, Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7893131/ https://www.ncbi.nlm.nih.gov/pubmed/33608636 http://dx.doi.org/10.1038/s41375-021-01175-8

Ejemplares similares

Introduction of mandatory masking in health care and community: experience from Jena, Germany
por: Pletz, Mathias W., et al.
Publicado: (2023)

Persistent T-Cell Reactivity in a Seronegative Patient after SARS-CoV-2 Infection and One Vaccination
por: Andreas, Nico, et al.
Publicado: (2022)

Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host
por: Choi, Bina, et al.
Publicado: (2020)

Persistent humoral and CD4(+) T(H) cell immunity after mild SARS-COV-2 infection—The CoNAN long-term study
por: Schnizer, Clara, et al.
Publicado: (2023)

A scoping review of regulatory T cell dynamics in convalescent COVID-19 patients – indications for their potential involvement in the development of Long COVID?
por: Haunhorst, Simon, et al.
Publicado: (2022)

Folgen nach SARS-CoV-2-Infektion einschließlich Post-COVID-Syndrom
por: Quickert, Stefanie, et al.
Publicado: (2023)

Risk Factors for Multi-Drug Resistant Pathogens and Failure of Empiric First-Line Therapy in Acute Cholangitis
por: Reuken, Philipp A., et al.
Publicado: (2017)

Correction: Risk Factors for Multi-Drug Resistant Pathogens and Failure of Empiric First-Line Therapy in Acute Cholangitis
por: Reuken, Philipp A., et al.
Publicado: (2017)

Post-COVID-19 condition is not only a question of persistent symptoms: structured screening including health-related quality of life reveals two separate clusters of post-COVID
por: Giszas, Benjamin, et al.
Publicado: (2022)

Characterization of neurocognitive deficits in patients with post-COVID-19 syndrome: persistence, patients’ complaints, and clinical predictors
por: Kozik, Valeska, et al.
Publicado: (2023)

The impact of specific cytokine directed treatment on severe COVID-19
por: Reuken, P. A., et al.
Publicado: (2021)

Infliximab against severe COVID-19-induced cytokine storm syndrome with organ failure—a cautionary case series
por: Stallmach, Andreas, et al.
Publicado: (2020)

Long COVID: a narrative review of the clinical aftermaths of COVID-19 with a focus on the putative pathophysiology and aspects of physical activity
por: Haunhorst, Simon, et al.
Publicado: (2022)

Ruling out COVID-19 by chest CT at emergency admission when prevalence is low: the prospective, observational SCOUT study
por: Teichgräber, Ulf, et al.
Publicado: (2021)

Complicated Long Term Vaccine Induced Thrombotic Immune Thrombocytopenia—A Case Report
por: Günther, Albrecht, et al.
Publicado: (2021)

Self-assessment of treatment targets in patients with inflammatory bowel disease using a survey
por: Reuken, Philipp A., et al.
Publicado: (2020)

Comparison of fatigue, cognitive dysfunction and psychological disorders in post-COVID patients and patients after sepsis: is there a specific constellation?
por: Stallmach, Andreas, et al.
Publicado: (2022)

Infliximab in the treatment of patients with severe COVID-19 (INFLIXCOVID): protocol for a randomised, controlled, multicentre, open-label phase II clinical study
por: Coldewey, Sina M., et al.
Publicado: (2022)

Gastrointestinal Infections and the Risk of Inflammatory Bowel Disease in Twins and Siblings: Evidence Against the Hygiene Hypothesis
por: Teich, Niels, et al.
Publicado: (2022)

Development and validation of a simple and robust model to predict 30-day mortality in patients with Clostridioides difficile-associated enterocolitis
por: Katzer, Katrin Claudia, et al.
Publicado: (2020)

Recurrent Disseminated Intravascular Coagulation in Metastatic Castration-Resistant Prostate Cancer: A Case Report
por: Giszas, Benjamin, et al.
Publicado: (2022)

A novel SARS-CoV-2 IgG line-blot for evaluating discrepant IgG test results – Observations in pre-pandemic and follow-up samples of five patients
por: Steiner, Andrea, et al.
Publicado: (2021)

Rat Hepatitis E in an Immunocompromised Patient
por: Hon, Kam Lun, et al.
Publicado: (2020)

Successful use of nirmatrelvir/ritonavir in immunocompromised patients with persistent and/or relapsing COVID-19
por: Graziani, Lucia, et al.
Publicado: (2022)

SARS-CoV-2 Evolution and Immune Escape in Immunocompromised Patients
por: Scherer, Erin M., et al.
Publicado: (2022)

Detection of Liver Dysfunction Using a Wearable Electronic Nose System Based on Semiconductor Metal Oxide Sensors
por: Voss, Andreas, et al.
Publicado: (2022)

Electrical Impedance Tomography (EIT) in a Patient Suffering from Post-COVID Syndrome with Dyspnea: A Case Report
por: Katzer, Katrin, et al.
Publicado: (2022)

Another trial for the TARGET trial. Author’s reply
por: Hagel, Stefan, et al.
Publicado: (2022)

Concerns about study design and suggestion of additional analysis of therapeutic drug monitoring-guided piperacillin/tazobactam therapy for patients with sepsis. Author’s reply
por: Hagel, Stefan, et al.
Publicado: (2022)

Paxlovid in patients who are immunocompromised and hospitalised with SARS-CoV-2 infection
por: Sun, Fangfang, et al.
Publicado: (2022)

Between fear and courage: Attitudes, beliefs, and behavior of liver transplantation recipients and waiting list candidates during the COVID-19 pandemic
por: Reuken, Philipp A., et al.
Publicado: (2020)

Early ribavirin for hepatitis E virus infection in patients receiving immunosuppressive therapy: a retrospective, observational study
por: Franz, Anika, et al.
Publicado: (2023)

Isoscartopic Response: Another Facet of the Immunocompromised Cutaneous District
por: Caccavale, Stefano, et al.
Publicado: (2016)

An Opportunity to Better Understand the Impact of Coronaviruses on Immunocompromised Patients
por: Parisi, Christina
Publicado: (2020)

Bamlanivimab as monotherapy in two immunocompromised patients with COVID-19
por: Destras, Grégory, et al.
Publicado: (2021)

The unmet need for COVID-19 treatment in immunocompromised patients
por: Alessandra, D’Abramo, et al.
Publicado: (2022)

Novel treatment combining antiviral and neutralizing antibody-based therapies with monitoring of spike-specific antibody and viral load for immunocompromised patients with persistent COVID-19 infection
por: Wada, Daiki, et al.
Publicado: (2022)

Sotrovimab drives SARS-CoV-2 omicron variant evolution in immunocompromised patients
por: Destras, Grégory, et al.
Publicado: (2022)

Persistent infections in immunocompromised hosts are rarely sources of new pathogen variants
por: Eden, John-Sebastian, et al.
Publicado: (2017)

Mucosal-Associated Invariant T Cells Redistribute to the Peritoneal Cavity During Spontaneous Bacterial Peritonitis and Contribute to Peritoneal Inflammation
por: Ibidapo-obe, Oluwatomi, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_rcoga8nm5ucuica89jjb09e1gv